Stroke and Tocotrienol: Unique Role in Neuroprotection

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT02263924

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02263924
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Malaysia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02263924. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stroke and Tocotrienol: Unique Role in Neuroprotection
Acronym
SATURN
Intervention (Dietary supplement)
Tocotrienol
Intervention (Dietary supplement)
Placebo capsules
Lead sponsor
Seberang Jaya Clinical Research Centre (class: other government)
Collaborator
Clinical Research Centre Hospital Taiping (class: not stated)
Collaborator
Universiti Sains Malaysia (class: other)

Record details

Record id
cardio:ct-nct02263924
Content hash
e4730f6cb1d54947d921a92ca020b607a9b10d86a1e42eb1f5616c3b59afe19e